Size at birth, maternal weight, and type 2 diabetes in South India. 1998

C H Fall, and C E Stein, and K Kumaran, and V Cox, and C Osmond, and D J Barker, and C N Hales
MRC Environmental Epidemiology Unit, Southampton General Hospital, UK.

Recent research in Europe and the USA has shown that adults who had a low birthweight or who were thin at birth with a low ponderal index (birthweight/length3) tend to be insulin resistant and have an increased risk of developing Type 2 diabetes mellitus. Low birthweight and Type 2 diabetes are common in India. We have studied glucose and insulin metabolism in 506 men and women (aged 39-60 years) born in a hospital in Mysore, South India, which kept detailed obstetric records from 1934. The prevalence of Type 2 diabetes was 15%. In contrast to Western populations, higher rates were found in men and women who were short at birth (p = 0.07) and had a high ponderal index (p = 0.05). Their mothers tended to be heavier than average during pregnancy (p = 0.004). Higher ponderal index at birth was also associated with a lower 30 minute insulin increment (p = 0.009), a marker of reduced beta cell function. We speculate that the rise in Type 2 diabetes in Indian urban populations may have been triggered by mild obesity in mothers, leading to glucose intolerance during pregnancy, macrosomic changes in the fetus, and insulin deficiency in adult life.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011384 Proinsulin A pancreatic polypeptide of about 110 amino acids, depending on the species, that is the precursor of insulin. Proinsulin, produced by the PANCREATIC BETA CELLS, is comprised sequentially of the N-terminal B-chain, the proteolytically removable connecting C-peptide, and the C-terminal A-chain. It also contains three disulfide bonds, two between A-chain and B-chain. After cleavage at two locations, insulin and C-peptide are the secreted products. Intact proinsulin with low bioactivity also is secreted in small amounts.
D001724 Birth Weight The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms. Birthweight,Birth Weights,Birthweights,Weight, Birth,Weights, Birth
D001824 Body Constitution The physical characteristics of the body, including the mode of performance of functions, the activity of metabolic processes, the manner and degree of reactions to stimuli, and power of resistance to the attack of pathogenic organisms. Body Constitutions,Constitution, Body,Constitutions, Body
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body

Related Publications

C H Fall, and C E Stein, and K Kumaran, and V Cox, and C Osmond, and D J Barker, and C N Hales
September 2006, Obstetrics and gynecology,
C H Fall, and C E Stein, and K Kumaran, and V Cox, and C Osmond, and D J Barker, and C N Hales
April 2009, JAMA,
C H Fall, and C E Stein, and K Kumaran, and V Cox, and C Osmond, and D J Barker, and C N Hales
April 2009, JAMA,
C H Fall, and C E Stein, and K Kumaran, and V Cox, and C Osmond, and D J Barker, and C N Hales
January 2005, Nestle Nutrition workshop series. Paediatric programme,
C H Fall, and C E Stein, and K Kumaran, and V Cox, and C Osmond, and D J Barker, and C N Hales
September 2011, Journal of women's health (2002),
C H Fall, and C E Stein, and K Kumaran, and V Cox, and C Osmond, and D J Barker, and C N Hales
June 2009, Diabetes,
C H Fall, and C E Stein, and K Kumaran, and V Cox, and C Osmond, and D J Barker, and C N Hales
December 2017, Experimental and therapeutic medicine,
C H Fall, and C E Stein, and K Kumaran, and V Cox, and C Osmond, and D J Barker, and C N Hales
April 2007, The Journal of nutrition,
C H Fall, and C E Stein, and K Kumaran, and V Cox, and C Osmond, and D J Barker, and C N Hales
March 2006, The British journal of psychiatry : the journal of mental science,
C H Fall, and C E Stein, and K Kumaran, and V Cox, and C Osmond, and D J Barker, and C N Hales
April 2016, Diabetes,
Copied contents to your clipboard!